Quantcast
Last updated on April 17, 2014 at 14:44 EDT

Latest Registration Statement Stories

2014-02-27 20:23:05

GREENWOOD VILLAGE, Colo., Feb. 27, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that it has priced an underwritten public offering of 8,500,000 shares of its common stock. The shares will be sold at a price to the public of $7.00 per share for gross proceeds of $59.5 million. (Logo: http://photos.prnewswire.com/prnh/20120516/MM09116LOGO) Citigroup Global Markets Inc. and Jefferies LLC are acting as joint book-running managers for the...

2014-02-27 16:33:34

OR YEHUDA, Israel, Feb. 27, 2014 /PRNewswire/ -- Magic Software Enterprises Ltd. (NASDAQ and TASE: MGIC) (the "Company"), a global provider of mobile and cloud-enabled application development and business integration platforms, announced today its intention to offer and sell ordinary shares of the Company in an underwritten offering pursuant to its existing shelf registration statement. The Company intends to grant to the underwriters an option to purchase additional ordinary...

2014-02-27 12:28:01

PORTLAND, Ore., Feb. 27, 2014 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ: SMLR), an emerging medical risk-assessment company whose mission is to develop, manufacture and market patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services, today announced the closing of its previously announced initial public offering of 1,430,000 shares of its common stock offered at a price to the...

2014-02-27 08:30:25

BLUE BELL, Pa., Feb. 27, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) ("Inovio" or the "Company"), today announced the pricing of an underwritten public offering of 18,966,000 shares of common stock for a public offering price of $2.90 per share. The gross proceeds to Inovio from this offering are expected to be approximately $55 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company. The...

2014-02-26 20:22:32

SAN DIEGO, Feb. 26, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the pricing of an underwritten public offering of 8,000,000 shares of its common stock at a price to the public of $17.75 per share. The gross proceeds to Neurocrine from this offering, before deducting underwriting discounts and commissions and other offering expenses payable by Neurocrine, are expected to be approximately $142 million. The offering is expected to close on or...

2014-02-26 08:35:46

MCLEAN, Va., Feb. 26, 2014 /PRNewswire/ -- WidePoint Corporation (NYSE Mkt: WYY), a leading provider of secure, cloud-based, enterprise-wide solutions and services in mobile communications management and identity management, announced today the pricing of an underwritten public offering of 7,876,497 shares of its common stock at a purchase price of $1.38 per share. The gross proceeds to the Company from this offering are expected to be approximately $10.9 million, before deducting...

2014-02-25 16:34:33

MCLEAN, Va., Feb. 25, 2014 /PRNewswire/ -- WidePoint Corporation (NYSE Mkt: WYY), a leading provider of secure, cloud-based, enterprise-wide solutions and services in mobile communications management and identity management, announced today that it intends to offer shares of its common stock in an underwritten public offering. All of the shares in the offering are to be sold by WidePoint. WidePoint also expects to grant the underwriter a 30-day option to purchase additional shares of...

2014-02-25 16:29:29

SAN DIEGO, Feb. 25, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it is offering to sell 7,000,000 shares of its common stock in an underwritten public offering. In connection with this offering, Neurocrine will also grant to the underwriters a 30-day option to purchase up to an additional 1,050,000 shares of common stock. Jefferies LLC and J.P. Morgan Securities LLC are acting as joint book-running managers for this offering. The offering is...

2014-02-25 16:24:26

HOUSTON and LONDON, Feb. 25, 2014 /PRNewswire/ -- LyondellBasell Industries N.V. (NYSE: LYB) today announced that LYB International Finance B.V., its wholly-owned subsidiary, priced its public offering of $1 billion aggregate principal amount of 4.875% Guaranteed Notes due 2044 (the "Notes"). The Notes are fully and unconditionally guaranteed by LyondellBasell Industries. The offering is expected to close on Feb. 28, 2014, subject to customary closing conditions. The proceeds of the...

2014-02-25 16:24:23

TULSA, Okla., Feb. 25, 2014 /PRNewswire/ -- Magellan Midstream Partners, L.P. (NYSE: MMP) announced today that it has priced $250 million of its 5.15% senior notes due 2043. The notes, which are additional notes of the series originally issued on Oct. 10, 2013, were priced at 103.085% of par to yield 4.95% to maturity. The partnership intends to use the net proceeds from this offering of approximately $255 million, after underwriting discounts, estimated offering expenses and accrued...